🔥🐔 BizChicken 🐔🔥

Learn About the Corporations Around You

Sign Up Today!

Sign up for BizChicken and discover more about the corporations around you.

Lyra Therapeutics, Inc.

Lyra Therapeutics, Inc. logo
Market Cap: Lowest
Employees: Low

XTreo technology platform

Lyra Therapeutics, Inc. is a clinical-stage therapeutics company developing integrated drug and delivery solutions for ear, nose, and throat diseases using its XTreo technology platform. It focuses on product candidates like LYR-210 and LYR-220 for chronic rhinosinusitis.

Tags: biotechnology, chronic rhinosinusitis, drug delivery, healthcare, therapeutics

Website

About | About | About | Leadership | Contact | About | Culture | Careers | Careers | Contact

Symbol: LYRA

Recent Price: $0.22

Industry: Biotechnology

CEO: Dr. Maria Palasis Ph.D.

Sector: Healthcare

Employees: 88

Address: 480 Arsenal Way, Watertown, MA 02472

Phone: 617 393 4600

Leadership

  • Harlan W. Waksal, M.D., Executive Chairman
  • Maria Palasis, Ph.D., President and Chief Executive Officer
  • Jason Cavalier, Chief Financial Officer
  • Robert Kern, M.D., Chief Clinical Advisor
  • Ronan O’Brien, Chief Legal Officer
  • Vineeta Belanger, Ph.D., Senior Vice President of Clinical Affairs
  • Gloria Cosgrove, Senior Vice President of Quality
  • Allison Nance, Senior Vice President of Regulatory Affairs
  • Michael Altman, CFA, Managing Director, Perceptive Advisors
  • Ann Merrifield, Life Sciences Advisor and Board Director
  • Konstantin Poukalov, Managing Director, Perceptive Advisors
  • Bradford Smith, Board Director
  • Nancy L. Snyderman, M.D., Board Director
  • Jim Tobin, Lead Independent Director
  • Robert Langer, D.Sc., David H. Koch Institute Professor, Massachusetts Institute of Technology
  • George Whitesides, Ph.D., Woodford L. and Ann A. Flowers University Professor, Harvard University

Last updated: 2024-12-31